Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B

Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh

Clin Mol Hepatol. 2017;23(4):331-339. Published online September 26, 2017

DOI: https://doi.org/10.3350/cmh.2016.0040

View: 8520 Download: 222 Web of Science: 14 Crossref: 10

No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients

Nae-Yun Heo, Young-Suk Lim, Woochang Lee, Minkyung Oh, Jiyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh

Clin Mol Hepatol. 2014;20(2):177-184. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.177

View: 7319 Download: 58 Web of Science: 4 Crossref: 4

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

Hyun Young Woo, Jong Young Choi, Seung Kew Yoon, Dong Jin Suh, Seung Woon Paik, Kwang Hyub Han, Soon Ho Um, Byung Ik Kim, Heon Ju Lee, Mong Cho, Chun Kyon Lee, Dong Joon Kim, Jae Seok Hwang

Clin Mol Hepatol. 2014;20(2):168-176. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.168

View: 8515 Download: 63 Web of Science: 4 Crossref: 2

High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice

Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Yung Sang Lee, Kang Mo Kim, Kwan Soo Byun, Kwang-Hyub Han, Kwan Sik Lee, Seung Woon Paik, Seung Kew Yoon, Dong Jin Suh

Clin Mol Hepatol. 2013;19(1):60-69. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.60

View: 8839 Download: 61 Web of Science: 6 Crossref: 7

Case Report

Osler-Weber-Rendu disease presenting with hepatocellular carcinoma: radiologic and genetic findings

Joo Ho Lee, Yung Sang Lee, Pyo Nyun Kim, Beom Hee Lee, Gu-Whan Kim, Han-Wook Yoo, Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Dong Jin Suh

Clin Mol Hepatol. 2011;17(4):313-318. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.313

View: 9644 Download: 61 Crossref: 7

Original Article

Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center

Sung Eun Kim, Han Chu Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh

Clin Mol Hepatol. 2011;17(2):113-119. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.113

View: 8867 Download: 49 Crossref: 25

1 |

Viewed By 4992	MAFLD: How is it different from NAFLD?
Viewed By 4841	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4772	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4490	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4443	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 95	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search